logo

MEI Pharma Secures Over $100 Million Funding Commitment to Launch Litecoin Treasury Strategy

By: theblockbeats.news|2025/07/18 16:42:12

BlockBeats News, July 19th, Titan Partners Group and crypto investment firm GSR are co-leading a strategic transformation of the US pharmaceutical company MEI Pharma (NASDAQ: MEIP), driving the establishment of a dedicated Litecoin treasury strategy. Currently, there has been over $100 million in funding commitments to this project.


It is worth mentioning that Litecoin creator Charlie Lee has agreed to join the MEI Pharma board of directors. Furthermore, the Litecoin Foundation has also invested in MEI Pharma as the company's treasury strategy aligns closely with the Litecoin Foundation's core mission of promoting global Litecoin adoption.

EstateX (ESX) Prognose: Rallye auf 0,01 $ trotz Skeptikern?
WEEX stiehlt BlockchainRIO 2025 die Show

Das könnte Ihnen auch gefallen

Teilen
copy

Gewinner

Neueste Krypto-Nachrichten

11:24

24-Stunden Spot Funding Zu-/Abflussliste: ETH Nettoabfluss von 126 Mio. $, ZEC Nettoabfluss von 18,2 Mio. $

11:20

Bloomberg: Fed spaltet sich bei langfristiger Zinsstrategie nie so sehr

10:55

Schlüsseltransaktionsdaten: US 10-jährige Treasury-Rendite steigt auf 4,086%

10:53

Mainstream Perp DEX Übersicht: Hyperliquid übersteigt erneut Handelsvolumen von 10 Milliarden US-Dollar, Plattformvolumen erholt sich gemeinsam

10:50

Die European Stablecoin Alliance ernennt ehemaligen Coinbase Executive zum Chief Executive Officer

Mehr lesen
Community
icon
icon
icon
icon
icon
icon
icon
icon

Kundenservice@weikecs

Geschäftliche Zusammenarbeit@weikecs

Quant-Trading & MM[email protected]

VIP-Services[email protected]